企業プロフィール
Vir Biotechnology 株価・ニュース・カタリスト
- ティッカー:
- VIR
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
9.91 USD (+1.33%)
終値
最終更新: 2026年8月24日
1.47B USD
時価総額
株価変動の要因
As of Aug 24, 2026, VIR closed up 1.33% at $9.91. No new same-company headline was identified in the current news window.
企業概要
事業概要
Vir Biotechnology is an immunology and infectious-disease company built around antibody science and platform partnerships.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Vir sits in specialty biotechnology.
ビジネスモデルの特徴
Its model depends on clinical development, collaboration revenue, and finding durable programs beyond the pandemic era.
バイオ業界での位置付け
Vir remains a platform-heavy biotech name, but investors need the pipeline to deliver clear differentiation to keep the story moving.
今後のカタリスト
- Vir Biotechnology's catalysts are tobevibart plus elebsiran in hepatitis D, along with the rest of the hepatitis B franchise. The stock will care about whether the antiviral platform can keep finding a clear regulatory and commercial path.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。